(Q43708064)

26 November 2017

Levodopa induces dyskinesias in normal squirrel monkeys (English)

1 reference

26 November 2017

1 reference

1 reference

Togasaki DM

1

1 reference

26 November 2017

Tan L

2

1 reference

26 November 2017

Protell P

3

1 reference

26 November 2017

Di Monte DA

4

1 reference

26 November 2017

Quik M

5

1 reference

26 November 2017

Langston JW

6

1 reference

26 November 2017

1 August 2001

1 reference

26 November 2017

1 reference

26 November 2017

50

1 reference

26 November 2017

2

1 reference

26 November 2017

254-257

1 reference

Analysis of L-dopa induced dyskinesias in 51 patients with Parkinsonism

26 November 2017

1 reference

Is levodopa toxic to human substantia nigra?

21 January 2018

1 reference

Nigrostriatal damage is required for induction of dyskinesias by L-DOPA in squirrel monkeys

21 January 2018

1 reference

Levodopa-induced dyskinesias in parkinsonian monkeys: relationship to extent of nigrostriatal damage

21 January 2018

1 reference

Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).

21 January 2018

1 reference

Treatment failures with levodopa in Parkinsonism

21 January 2018

1 reference

The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey.

21 January 2018

1 reference

21 January 2018

1 reference

Changes in brain dopamine receptors in MPTP parkinsonian monkeys following L-dopa treatment

21 January 2018

1 reference

Hyperkinesia and changes in behavior produced in normal monkeys by L-dopa

21 January 2018

1 reference

Levodopa therapy: consequences of the nonphysiologic replacement of dopamine

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.1099

1 reference

26 November 2017

1 reference